- /
- Supported exchanges
- / US
- / TXG.NASDAQ
10X Genomics Inc (TXG NASDAQ) stock market data APIs
10X Genomics Inc Financial Data Overview
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with 10X Genomics Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get 10X Genomics Inc data using free add-ons & libraries
Get 10X Genomics Inc Fundamental Data
10X Genomics Inc Fundamental data includes:
- Net Revenue: 644 M
- EBITDA: -110 854 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-28
- EPS/Forecast: -0.07
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
10X Genomics Inc News
New
Q3 Results Spark After-Hours Surge In GMED, TNDM, ICUI, ORGO, SKIN, TXG
(RTTNews) - A wave of earnings releases and revised 2025 guidance triggered strong after-hours gains across several healthcare and life sciences stocks on Thursday. Globus Medical (GMED) surged 24.37...
10x Genomics signals 5% sequential revenue growth for Q4 2025 as new product launches drive adoption
Earnings Call Insights: 10x Genomics (TXG) Q3 2025 MANAGEMENT VIEW * Serge Saxonov, CEO and Co-Founder, outlined that the company "exceeded the top end of our guidance range in the third quarter w...
Torex Gold Reports Q3 2025 Results
Excellent operational results drive return to strong quarterly free cash flow, demonstrating the forward value-generating potential of Morelos (All amounts expressed in U.S. dollars unless otherwise ...
Torex Gold Announces Initial Return of Capital Program
Combination of dividends and share repurchases reflects significant cash flow generation following successful completion of Media Luna (All amounts expressed in U.S. dollars unless otherwise stated) ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.